新入荷 再入荷

Discovery of Phenylcarbamoylazinane-1,2,4-Triazole Amides Derivatives as the Potential Inhibitors of Aldo-Keto Reductases (AKR1B1 & AKRB10): Potential Lead Molecules for Treatment of Colon Cancer

flash sale icon タイムセール
終了まで
00
00
00
999円以上お買上げで送料無料(
999円以上お買上げで代引き手数料無料
通販と店舗では販売価格や税表示が異なる場合がございます。また店頭ではすでに品切れの場合もございます。予めご了承ください。
新品 10800円 (税込)
数量

Discovery of Phenylcarbamoylazinane-1,2,4-Triazole Amides Derivatives as the Potential Inhibitors of Aldo-Keto Reductases (AKR1B1 & AKRB10): Potential Lead Molecules for Treatment of Colon Cancer

Discovery of Phenylcarbamoylazinane-1,2,4-Triazole Amides Derivatives as  the Potential Inhibitors of Aldo-Keto Reductases (AKR1B1 & AKRB10):  Potential Lead Molecules for Treatment of Colon CancerDiscovery of Phenylcarbamoylazinane-1,2,4-Triazole Amides Derivatives as the Potential Inhibitors of Aldo-Keto Reductases (AKR1B1 & AKRB10): Potential Lead Molecules for Treatment of Colon Cancer,Metabolic Adaptation-Mediated Cancer Survival and Progression in Oxidative  StressMetabolic Adaptation-Mediated Cancer Survival and Progression in Oxidative Stress,Discovery of Phenylcarbamoylazinane-1,2,4-Triazole Amides Derivatives as  the Potential Inhibitors of Aldo-Keto Reductases (AKR1B1 & AKRB10):  Potential Lead Molecules for Treatment of Colon CancerDiscovery of Phenylcarbamoylazinane-1,2,4-Triazole Amides Derivatives as the Potential Inhibitors of Aldo-Keto Reductases (AKR1B1 & AKRB10): Potential Lead Molecules for Treatment of Colon Cancer,希少 稼動 1978年製 SEIKO グランドクォーツ デイデイト 腕時計 メンズ希少 稼動 1978年製 SEIKO グランドクォーツ デイデイト 腕時計 メンズ,MYC-mediated resistance to trametinib and HCQ in PDAC is overcome by CDK4/6  and lysosomal inhibition | Journal of Experimental Medicine | Rockefeller  University PressMYC-mediated resistance to trametinib and HCQ in PDAC is overcome by CDK4/6 and lysosomal inhibition | Journal of Experimental Medicine | Rockefeller University Press,

 

レディースの製品

商品情報の訂正

このページに記載された商品情報に記載漏れや誤りなどお気づきの点がある場合は、下記訂正依頼フォームよりお願い致します。

訂正依頼フォーム

商品レビュー

レビューの投稿にはサインインが必要です